KDM5B predicts temozolomide-resistant subclones in glioblastomaVivien Ullrich, Björn Scheffler, Martin Glas et al.|iScience|2023Cited by 4
DDDR-22. PREDICTING AND TARGETING CLONALLY EXPANDING, TMZ-RESISTANT TUMOR CELLS IN GLIOBLASTOMAVivien Ullrich, Björn Scheffler, Pia Berger et al.|Neuro-Oncology|2023Cited by 0